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A 68 YEAR OLD married woman was admitted to the Ulster Hospital, Belfast
in October 1975 with a one month history of generalized crampy abdominal
pain, abdominal swelling and increasing constipation. She had a myocardial
infarction in 1969 and a hemiplegia in 1972 and had recovered well from each.
She had been on treatment with practolol for three years for hypertension. In
1974 she attended an eye department because her eyes had "dried up" and
kerato-conjunctivitis sicca was diagnosed. There was epithelial damage to both
cornea with a deep central ulcer in the left cornea and visual acuity was reduced
to less than 50 per cent in each eye. Practolol was thought to be responsible and
was stopped. Her eyes improved with local treatment but tear secretion in the
left eye remained very reduced.
On examination she was a frail elderly patient wearing unusual spectacles
with plastic sidepieces. There was a mass arising out of the pelvis and reaching
to the umbilicus which was provisionally diagnosed as an ovarian tumour.
Her poor general condition due to generalized vascular disease made surgery
hazardous, and as she improved in hospital she was allowed home after two
weeks. One month later she was readmitted with a one week history of vomiting
and crampy abdominal pain. The abdominal swelling was unchanged. Despite
her poor general condition laparotomy was performed under an epidural
anaesthesia. The abdominal tumour was found to be dilated loops of small bowel
matted together by peritoneal adhesions. There was no ovarian tumour and the
pelvic organs were normal. The extensive adhesions were laboriously divided
to release the loops of small bowel following which the patient made a slow but
steady recovery and was discharged three weeks after operation. Four months
post-operatively she remains well.
DISCUSSION
There are several reports of sclerosing peritonitis arising after the use of
practolol (Brown et al, 1974, Windsor, Kurrein and Dyer, 1975, Trudinger and
Fitchett 1976). This patient is of particular interest as she presented in a
gynaecological department and we feel that the condition must now be consid-
ered as a differential diagnosis of an abdominal swelling in all patients who
have received practolol. It also illustrates the importance of carrying out a
laparotomy in order to establish a diagnosis in all suspect cases of ovarian
tumour, no matter how hopeless the situation seems.
This example of the "Practolol induced syndrome" demonstrates two of its
main manifestations.
1811. Effects on the eyes-If ocular changes occur there is a progressive dry-
ness which may eventually lead to inflammation. Filamentary or punctuate kera-
titis may then develop and may progress to corneal ulceration and impairment
or loss of vision. Secondary conjunctivitis may lead to scarring, especially in
the fornices (which become less deep) and may eventually progress to symble-
pharon or even entropion. These more severe eye changes have only been re-
ported when the syndrome was initially unrecognised and ingestion of practolol
continued.
2. Effects on the peritoneum-Recently cases have been reported of a
sclerosing peritonitis which presents with the signs and symptoms of abdominal
pain, sub-acute small bowel obstruction or an apparent abdominal mass but
with no tumour found at laparotomy. Some of the case reports have referred
to dry eyes and skin lesions apparently preceding the abdominal symptoms, but
in the absence of such detail in other reports, one cannot assume that this is
always the sequence of events.
This patient had been on practolol for three years which had been discon-
tinued when its association with her eye symptoms was recognised. Eighteen
months after this she presented with the peritoneal side effects of this therapy.
As she had had no previous abdominal surgery and as there was no evidence of
tuberculous peritonitis or of a neoplasm it is unlikely that the findings could
be explained on any other basis. This patient's only other long term medication
was Lanoxin (Wellcome) and such a complication with this drug has not been
described. At present it is recommended that practolol should only be used
to control cardiac arrhythmias in the immediate post-infarction period. Further
investigation of its side effects is being actively undertaken by the manufacturers,
but how practolol acts to cause the peritonitis is at present unknown.
SUMMARY
The administration of practolol for three years produced a sclerosing periton-
itis which simulated an ovarian tumour presenting eighteen months after therapy
had been stopped.
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